Markets:

Overview

News

Currencies

International

Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

24.57 +6.05 (+32.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Why Tandem Diabetes Care Stock Popped Today ↗

February 20, 2026

The med tech supplier is shifting to a more predictable and lucrative business model.

Via The Motley Fool

Topics Supply Chain

Why Are Tandem Diabetes (TNDM) Shares Soaring Today

February 20, 2026

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 30.2% in the afternoon session after the company reported better-than-expected fourth-quarter financial results.

Via StockStory

Topics Artificial Intelligence Supply Chain

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

February 20, 2026

Via Chartmill

Top movers in Friday's session ↗

February 20, 2026

Via Chartmill

Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Strong Q4 Beat but Issues Cautious 2026 Sales Guidance ↗

February 19, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

February 20, 2026

Via Chartmill

Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? ↗

February 20, 2026

For the full year, Tandem reported $1.015 billion in worldwide sales and over 126,000 pump shipments.

Via Stocktwits

Topics Earnings

Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates

February 19, 2026

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. On the other hand, the company’s...

Via StockStory

Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues

February 18, 2026

Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...

Via MarketMinute

Topics Earnings

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Question

February 15, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds

February 02, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

3 Stocks Under $50 That Fall Short

January 29, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Chart Industries Exit Comes With a $210 Takeout Clock and $6 Billion Backlog ↗

January 29, 2026

Chart Industries supplies cryogenic and heat transfer equipment to energy, industrial gas, and specialty markets worldwide.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Knife River Stock Has Tumbled 31% This Past Year, but One Fund Placed a $22 Million Bet on a Turnaround ↗

January 29, 2026

Knife River delivers construction materials and services for large U.S. infrastructure projects, serving both public and private clients.

Via The Motley Fool

3 Reasons to Avoid TNDM and 1 Stock to Buy Instead

January 25, 2026

Over the past six months, Tandem Diabetes has been a great trade, beating the S&P 500 by 9.6%. Its stock price has climbed to $19.83, representing a healthy 17.8% increase. This was partly due to its...

Via StockStory

Topics Bankruptcy Stocks

Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)

January 09, 2026

Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully...

Via PredictStreet

Topics Economy Product Recall World Trade

Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

December 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with...

Via StockStory

Don't Buy Tandem Diabetes Care Until This Big Thing Happens ↗

December 12, 2025

The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.

Via The Motley Fool

Topics Government World Trade

1 Small-Cap Stock to Consider Right Now and 2 We Brush Off

December 07, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Topics Firearms

Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know

December 03, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 4.5% in the afternoon session after an analyst at Morgan Stanley raised the firm's price target for the stock. The firm's...

Via StockStory

Topics Artificial Intelligence Economy Supply Chain

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

2 Momentum Stocks with Solid Fundamentals and 1 We Turn Down

November 21, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

Topics Economy

5 Insightful Analyst Questions From Tandem Diabetes’s Q3 Earnings Call

November 13, 2025

Tandem Diabetes’ third quarter was marked by improved operational efficiency and commercial execution, resulting in a positive market reaction. Management credited the quarter’s performance to the...

Via StockStory

Topics Earnings

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

3 Russell 2000 Stocks We Think Twice About

November 09, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Why Is Tandem Diabetes (TNDM) Stock Soaring Today

November 07, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 20.3% in the afternoon session after the company reported third-quarter results that surpassed analyst expectations for...

Via StockStory

Topics Artificial Intelligence

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 07, 2025

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

TNDM Q3 Deep Dive: Commercial Transformation and New Product Initiatives Drive Results

November 07, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.6% year on year to $249.3 million. Its GAAP loss...

Via StockStory

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.